About the Webinar:
In November 2020, the U.S. Department of Health and Human Services Office of Inspector General (OIG) issued a Special Fraud Alert that draws attention to potential fraud and abuse risks for speaker programs.
Life Sciences companies can utilize this guidance to evaluate their speaker remuneration in light of the risks highlighted in the Special Fraud Alert. This webinar will analyze the Special Fraud Alert followed by a Q&A session.
Key Takeaways:
- Analysis of the Special Fraud Alert guidance in conjunction with Anti-Kickback Statute enforcement of speaker programs
- Framework to evaluate current speaker programs based on risks highlighted in the Special Fraud Alert
- A walk-through of potential fraud or abuse legal theories
- Key considerations for speaker programs to reduce fraud and abuse risks
- Implications of Special Fraud Alert for the Life Sciences industry
Who Should Attend:
Legal and compliance professionals, consultants dealing with Compliance Monitoring and/or HCP engagement at drug or medical device manufacturing companies.
